|
ISIN No
|
INE812Q01016
|
BSE Code / NSE Code
|
539040 / TIRUPATIIN
|
Book Value (Rs.)
|
14.66
|
Face Value
|
10.00
|
|
Bookclosure
|
30/04/2026
|
52Week High
|
14
|
EPS
|
0.09
|
P/E
|
107.58
|
|
Market Cap.
|
69.40 Cr.
|
52Week Low
|
8
|
P/BV / Div Yield (%)
|
0.67 / 0.00
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the entire text of Notes to accounts of the company for the latest year
| Year End :2025-03 |
n) Provisions:
A provision is recognized when the Company has a present obligation (legal or constructive) as a result of past
event, it is probable that an outflow of resources embodying economic benefits will be required to settle the
obligation and a reliable estimate can be made of the amount of the obligation. These estimates are reviewed each
reporting date and adjusted to reflect the current best estimates.
o) Borrowings:
There are no Borrowings in the company for the financial year 2024-25.
p) Trade payables:
These amounts represent liabilities for goods that have been acquired in the ordinary course of business from
suppliers. Trade payables are presented as current liabilities unless payment is not due within 12 months after the
reporting period.
q) Financial Instruments and Risk Review:
The Company's principal Financial Assets include investments, trade receivables, cash and cash equivalents, other
bank balances and loan. The Company's financial liabilities comprise of borrowings and trade payables.
|